Lanzamiento Enero 2027

Metaanálisis2011Financiado por la industria

Financiado en parte por Pfizer

Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis

Hackam DG, Woodward M, Newby LK, Bhatt DL, Shao M, Smith EE, Donner A, Mamdani M, Douketis JD, Arima H, Chalmers J, MacMahon S, Tirschwell DL, Psaty BM, Bushnell CD, Aguilar MI, Capampangan DJ, Werring DJ, De Rango P, Viswanathan A, Danchin N, Cheng CL, Yang YH, Verdel BM, Lai MS, Kennedy J, Uchiyama S, Yamaguchi T, Ikeda Y, Mrkobrada M

Circulation · 142 citas

Etiquetas de revisión

Financiado por la industria

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Metaanálisis (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Eventos clínicos como enfermedad o muerte

Quién lo pagó

Financiación
Financiado por la industria
Empresa
Pfizer
Gobierno
Canadian Institutes of Health Research

Según 2 financiadores declarados.

Publicación

Publicado
2011-10-18 · Circulation · vol. 124 · número 20 · págs. 2233–2242
Editorial
Lippincott Williams & Wilkins
Citado
187 citas · más que el 97% de estudios similares · 6.0× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
90 trabajos
Acceso
De pago
Áreas de investigación
Intracerebral and Subarachnoid Hemorrhage Research · Lipoproteins and Cardiovascular Health · Acute Ischemic Stroke Management
Palabras clave
statins, intracerebral hemorrhage, hemorrhagic stroke risk, cholesterol-lowering therapy, drug safety
MeSH
animals, humans, cerebral hemorrhage, hydroxymethylglutaryl-coa reductase inhibitors, case-control studies, cohort studies, randomized controlled trials as topic

30 autores

  • Daniel G. Hackam🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Mark Woodward🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • L. Kristin Newby🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Deepak L. Bhatt🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Mingyuan Shao🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Eric Edward Smith🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Allan Donner🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Muhammad Mamdani🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • James Demetrios Douketis🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center; McMaster University
  • Hisatomi Arima🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • John Philip Chalmers🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Stephen W MacMahon🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • David Tirschwell🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Bruce M. Psaty🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Cheryl Bushnell🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Maria I. Aguilar🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Dan J. Capampangan🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • David John Werring🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Paola De Rango🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Anand Viswanathan🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Nicolas Danchin🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Ching‐Lan Cheng🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Yea‐Huei Kao Yang🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • B.M. Verdel🇨🇦🇺🇸🇦🇺🇳🇱Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; Utrecht University; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Mei‐Shu Lai🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • James Kennedy🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Shinichiro Uchiyama🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Takenori Yamaguchi🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Yasuo Ikeda🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center
  • Marko Mrkobrada🇨🇦🇺🇸🇦🇺Western University; Brigham and Women's Hospital; The University of Sydney; Cleveland Clinic; University of Calgary; VA Boston Healthcare System; The George Institute for Global Health; Duke Medical Center

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

A recent large, randomized trial suggested that statins may increase the risk of intracerebral hemorrhage. Accordingly, we systematically reviewed the association of statins with intracerebral hemorrhage in randomized and observational data.

Methods and results

We screened 17 electronic bibliographic databases to identify eligible studies and consulted with experts in the field. We used DerSimonian-Laird random-effects models to compute summary risk ratios with 95% confidence intervals. Randomized trials, cohort studies, and case-control studies were analyzed separately. Only adjusted risk estimates were used for pooling observational data. We included published and unpublished data from 23 randomized trials and 19 observational studies. The complete data set comprised 248 391 patients and 14 784 intracerebral hemorrhages. Statins were not associated with an increased risk of intracerebral hemorrhage in randomized trials (risk ratio, 1.10; 95% confidence interval, 0.86-1.41), cohort studies (risk ratio, 0.94; 95% confidence interval, 0.81-1.10), or case-control studies (risk ratio, 0.60; 95% confidence interval, 0.41-0.88). Substantial statistical heterogeneity was evident for the case-control studies (I(2)=66%, P=0.01), but not for the cohort studies (I(2)=0%, P=0.48) or randomized trials (I(2)=30%, P=0.09). Sensitivity analyses by study design features, patient characteristics, or magnitude of cholesterol lowering did not materially alter the results.

Conclusions

We found no evidence that statins were associated with intracerebral hemorrhage; if such a risk is present, its absolute magnitude is likely to be small and outweighed by the other cardiovascular benefits of these drugs.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.